A nationwide follow-up survey reveals shifts in treatment selections after ART insurance coverage, highlighting implications for standardization.
After ART insurance coverage in Japan, overall CE diagnostic methods and CD138 adoption remained largely unchanged. However, facilities tended to adopt higher CD138 cutoff values and treatment selections shifted. Establishing unified diagnostic criteria and treatment protocols is warranted to support standardized CE care for future health insurance coverage.
No takes yet. Share an insight, caveat, or question.
Jwa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: